Pulse Biosciences, Inc. PLSE
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 8.23% | 51.89% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.23% | 51.89% | |||
| Cost of Revenue | -26.22% | 42.31% | |||
| Gross Profit | 419.35% | 675.00% | |||
| SG&A Expenses | 28.31% | -10.08% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 31.48% | 5.58% | |||
| Operating Income | -31.97% | -4.91% | |||
| Income Before Tax | -32.70% | -6.59% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -32.70% | -6.59% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -32.70% | -6.59% | |||
| EBIT | -31.97% | -4.91% | |||
| EBITDA | -32.41% | -5.01% | |||
| EPS Basic | -30.37% | -6.26% | |||
| Normalized Basic EPS | -30.39% | -6.29% | |||
| EPS Diluted | -30.37% | -6.26% | |||
| Normalized Diluted EPS | -30.39% | -6.29% | |||
| Average Basic Shares Outstanding | 1.77% | 0.30% | |||
| Average Diluted Shares Outstanding | 1.77% | 0.30% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||